Skip to main content
Clinical Trials/CTRI/2012/12/003176
CTRI/2012/12/003176
Completed
未知

Assessment of the efficacy of a 6-week randomized, controlled half-face treatment with topical formulae containing 4% ER2412 compared to placebo in healthy volunteers with oily skin.

OREAL RESEARCH0 sites37 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
OREAL RESEARCH
Enrollment
37
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
OREAL RESEARCH

Eligibility Criteria

Inclusion Criteria

  • Healthy male volunteers, aged 18 â?? 40 years
  • \-Skin phototype II \-V (Fitzpatrick)
  • \-Presenting an oily skin appearance on the face (sebum rate \>70 µg/cm2 30 min after degreasing on the forehead right and left)
  • \-Acne prone subjects showing the presence of facial acne (grade 2\-7 in the attached Leeds acne grade \- Appendix 1\), presenting at least 15 inflammatory lesions and at least 25 non\-inflammatory lesions on the face
  • \-Able to give written informed consent and to comply with the requirements of the study

Exclusion Criteria

  • \-Female subjects
  • \-Known hypersensitivity to any of the study drugs or constituents
  • \-Skin disorders affecting the study area which, in the supervisorâ??s / designatorâ??s judgment, would interfere with grading / assessment of skin response (e.g. severe acne grade 8\-9 in the Leeds Acne Grade, rosacea, eczema, seborrhoeic dermatitis, psoriasis, disorders of pigmentation, etc â?¦)
  • \-Use of systemic retinoids within the 6 months prior to participation in the study, and during the study
  • \-Any topical or systemic treatment that could interfere with the study treatments/assessments (topical benzoyl peroxide and other antiacne or antiseborreic products, antibiotics, corticosteroids, anti\-inflammatory drugsâ?¦) within the last 4 weeks prior to participation in the study, and during the study
  • \-Undergone a facial resurfacing procedure, i.e., chemical peel, laser resurfacing, dermabrasion, within the 6 months prior to participation in the study, and during the study
  • \-Any surgical treatment on the test areas
  • \-Subject reported or planning to sun\-bath or to overexpose to UV\-light (mountains sports, phototherapy, tanning salon useâ?¦) for aesthetic or therapeutic reason the month before the study start or during the study
  • \-Current use of immunosuppressive drugs and/or an organ transplant
  • \-Insulin\-dependent diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials